Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Tirzepatide (brand names Mounjaro and Zepbound) resulted in a decrease in 10.1 percent of body weight at six months and semaglutide (brand names Ozempic, Wegovy, and Rybelsus) resulted in a decrease of 5.8 percent of body weight at six months, according to a 2024 study in JAMA Internal Medicine
Numbered markings at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50
Legitimacy exists on a spectrum
The Fund may be susceptible to an increased risk of loss, including losses due to adverse events that affect the Funds investments more than the market as a whole, to the extent that the Funds investments are concentrated in the securities and/or other assets of a particular issuer or issuers, country, group of countries, region, market, industry, group of industries, sector, market segment or asset class
